Abstract
1. Ketanserin or slow-release nifedipine were added to the treatment of 24 patients with hypertension uncontrolled by a thiazide diuretic plus beta-adrenoceptor antagonist in an observer-blind, randomised parallel-group study of 6 months duration. 2. At 6 months the mean falls in supine blood pressure were for ketanserin (mean daily dose 77 mg) 7/5 mm Hg and for nifedipine (mean daily dose 62 mg) 27/10 mm Hg. The difference between the treatments was significant for systolic blood pressure (P less than 0.02) and mean arterial pressure (P less than 0.05). Six nifedipine-treated patients reached target blood pressure, compared with one patient with ketanserin (P less than 0.02). 3. One patient taking nifedipine, and none taking ketanserin withdrew because of side-effects. The tolerability of the two drugs was broadly similar. 4. Ketanserin treatment was associated with significant changes in supine pulse rate (-8 beats min-1, P less than 0.05) and corrected QT interval (+27 ms, P less than 0.05). Nifedipine treatment had no effect on these variables. The change in pulse rate was significantly different between the groups. 5. In patients treated with a diuretic and beta-adrenoceptor blocker who required additional treatment ketanserin was significantly inferior to nifedipine.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Amery A., Fagard R., Fiocchi R., Lijnen P., Staessen J., Vermylen J. Antihypertensive action and serotonin-induced platelet aggregation during long-term ketanserin treatment in hypertensive patients. J Cardiovasc Pharmacol. 1984 Jan-Feb;6(1):182–185. [PubMed] [Google Scholar]
- Beilin L. J., Bulpitt C. J., Coles E. C., Dollery C. T., Gear J. S., Harper G., Johnson B. F., Munro-Faure A. D., Turner S. C. Long-term antihypertensive drug treatment and blood pressure control in three hospital hypertension clinics. Br Heart J. 1980 Jan;43(1):74–79. doi: 10.1136/hrt.43.1.74. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bulpitt C. J., Dollery C. T. Side effects of hypotensive agents evaluated by a self-administered questionnaire. Br Med J. 1973 Sep 1;3(5878):485–490. doi: 10.1136/bmj.3.5878.485. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Freestone S., Silas J. H., Ramsay L. E. Sample size for short-term trials of antihypertensive drugs. Br J Clin Pharmacol. 1982 Aug;14(2):265–268. doi: 10.1111/j.1365-2125.1982.tb01971.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hedner T., Persson B. Ketanserin in combination with beta-adrenergic receptor blocking agents in the treatment of essential hypertension. Br J Clin Pharmacol. 1984 Nov;18(5):765–771. doi: 10.1111/j.1365-2125.1984.tb02540.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McAreavey D., Ramsey L. E., Latham L., McLaren A. D., Lorimer A. R., Reid J. L., Robertson J. I., Robertson M. P., Weir R. J. "Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic. Br Med J (Clin Res Ed) 1984 Jan 14;288(6411):106–111. doi: 10.1136/bmj.288.6411.106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McGourty J. C., Silas J. H., Cowen K. J. Controlled trial of ketanserin in hypertension. Br J Clin Pharmacol. 1985 Jul;20(1):37–40. doi: 10.1111/j.1365-2125.1985.tb02795.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ramsay L. E., Parnell L., Waller P. C. Comparison of nifedipine, prazosin and hydralazine added to treatment of hypertensive patients uncontrolled by thiazide diuretic plus beta-blocker. Postgrad Med J. 1987 Feb;63(736):99–103. doi: 10.1136/pgmj.63.736.99. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wenting G. J., Man in 't Veld A. J., Woittiez A. J., Boomsma F., Schalekamp M. A. Treatment of hypertension with ketanserin, a new selective 5-HT2 receptor antagonist. Br Med J (Clin Res Ed) 1982 Feb 20;284(6315):537–539. doi: 10.1136/bmj.284.6315.537. [DOI] [PMC free article] [PubMed] [Google Scholar]